Bariatric therapy with intragastric balloon improves liver dysfunction and insulin resistance in obese patients. (Q46679914)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18369681%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

title

Bariatric therapy with intragastric balloon improves liver dysfunction and insulin resistance in obese patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18369681%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18369681%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

author name string

Gianluca Bersani

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18369681%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Angelo Rossi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18369681%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Flavia Pigò

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18369681%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Giovanni De Fabritiis

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18369681%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Vittorio Alvisi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18369681%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

publication date

28 March 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18369681%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

number of pages

5

1 reference

inferred from page(s)

published in

Obesity Surgery

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18369681%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18369681%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

page(s)

1438-1442

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18369681%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18369681%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s11695-008-9487-x

4 January 2020

exact match

0 references

cites work

Aminotransferase and gamma-glutamyltranspeptidase levels in obesity are associated with insulin resistance and the metabolic syndrome.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11695-008-9487-X

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

21 January 2018

1 reference

12 December 2020

Beyond insulin resistance in NASH: TNF-alpha or adiponectin?

1 reference

12 December 2020

Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life

1 reference

12 December 2020

Review: The role of insulin resistance in nonalcoholic fatty liver disease

1 reference

12 December 2020

Intragastric balloon insertion increases the frequency of erosive esophagitis in obese patients.

1 reference

12 December 2020

Relationship of Liver Enzymes to Insulin Sensitivity and Intra-Abdominal Fat

1 reference

12 December 2020

Insulin resistance: a metabolic pathway to chronic liver disease

1 reference

12 December 2020

BioEnterics Intragastric Balloon (BIB): a short-term, double-blind, randomised, controlled, crossover study on weight reduction in morbidly obese patients

1 reference

12 December 2020

The effect of loss of excess weight on the metabolic risk factors after bariatric surgery in morbidly and super-obese patients

1 reference

12 December 2020

Intragastric balloon for treatment-resistant obesity: safety, tolerance, and efficacy of 1-year balloon treatment followed by a 1-year balloon-free follow-up.

1 reference

12 December 2020

Behavior therapy for nonalcoholic fatty liver disease: The need for a multidisciplinary approach

1 reference

12 December 2020

Weight loss and non-alcoholic fatty liver disease: falls in gamma-glutamyl transferase concentrations are associated with histologic improvement.

1 reference

12 December 2020

The role of bright liver echo pattern on ultrasound B-mode examination in the diagnosis of liver steatosis.

1 reference

12 December 2020

Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance, adiponectin, and visceral fat

1 reference

12 December 2020

Intragastric balloon for obesity: a retrospective evaluation of tolerance and efficacy.

1 reference

12 December 2020

Higher concentrations of alanine aminotransferase within the reference interval predict nonalcoholic fatty liver disease

1 reference

12 December 2020

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

12 December 2020